Cited 0 time in
The Role of OnabotulinumtoxinA in Urology: What Is the Next Step?
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Moon, Hong Sang | - |
| dc.date.accessioned | 2022-07-15T19:57:09Z | - |
| dc.date.available | 2022-07-15T19:57:09Z | - |
| dc.date.issued | 2015-12 | - |
| dc.identifier.issn | 2093-4777 | - |
| dc.identifier.issn | 2093-6931 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/155692 | - |
| dc.format.extent | 2 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Association of Medical Journal Edirors | - |
| dc.title | The Role of OnabotulinumtoxinA in Urology: What Is the Next Step? | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5213/inj.2015.19.4.211 | - |
| dc.identifier.scopusid | 2-s2.0-84953742987 | - |
| dc.identifier.wosid | 000367300000001 | - |
| dc.identifier.bibliographicCitation | International Neurourology Journal, v.19, no.4, pp 211 - 212 | - |
| dc.citation.title | International Neurourology Journal | - |
| dc.citation.volume | 19 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 211 | - |
| dc.citation.endPage | 212 | - |
| dc.type.docType | Editorial Material | - |
| dc.identifier.kciid | ART002060063 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Urology & Nephrology | - |
| dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
| dc.subject.keywordPlus | botulinum toxin A | - |
| dc.subject.keywordPlus | liposome | - |
| dc.subject.keywordPlus | chronic prostatitis | - |
| dc.subject.keywordPlus | cystalgia | - |
| dc.subject.keywordPlus | drug safety | - |
| dc.subject.keywordPlus | Editorial | - |
| dc.subject.keywordPlus | follow up | - |
| dc.subject.keywordPlus | hematuria | - |
| dc.subject.keywordPlus | human | - |
| dc.subject.keywordPlus | interstitial cystitis | - |
| dc.subject.keywordPlus | long term care | - |
| dc.subject.keywordPlus | medication compliance | - |
| dc.subject.keywordPlus | neurotransmitter release | - |
| dc.subject.keywordPlus | overactive bladder | - |
| dc.subject.keywordPlus | pelvic pain | - |
| dc.subject.keywordPlus | pelvis pain syndrome | - |
| dc.subject.keywordPlus | postvoid residual urine volume | - |
| dc.subject.keywordPlus | recommended drug dose | - |
| dc.subject.keywordPlus | sensitization | - |
| dc.subject.keywordPlus | urinary tract infection | - |
| dc.subject.keywordPlus | urinary urgency | - |
| dc.subject.keywordPlus | urine incontinence | - |
| dc.subject.keywordPlus | urology | - |
| dc.subject.keywordAuthor | . | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
